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Abstract 
The antifungal drug amphotericin B is made by Streptomyces nodosus and is released 
into culture broths at concentrations exceeding its solubility in water.  The recent 
discovery of extracellular vesicles derived from Streptomyces species suggests that 
amphotericin B could be released from the biomass using this delivery system. This 
thesis identified a Streptomyces soil isolate through the construction of a 
phylogenetic tree based on 16S sequences. The soil isolate was used to develop 
methods to image Streptomyces extracellular vesicles using STEM, which were then 
used to examine whether S. nodosus produces extracellular vesicles. Initial 
co-localisation experiments using size fractionation indicated that amphotericin B 
was associated with fractions containing extracellular vesicles. Extracellular vesicles 
from the culture fluid of a mutant unable to produce amphotericin B, indicated that 
vesicle production was not dependent on amphotericin synthesis but may play a role 
in delivering other hydrophobic molecules. 
  
 
 
 
 
CHAPTER 1 
 
INTRODUCTION  
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1.1 The antifungal drug amphotericin B 
Antifungal drugs are used to treat a variety of fungal pathogens from superficial 
infections estimated to affect 25% of the human population (Havlickova et al 2008), 
to systemic mycoses occurring primarily in juvenile, elderly and 
immunocomprimised individuals (Richardson 2005). For systemic infections, three 
classes of drugs have been effective, polyenes, echinocandins and azoles (Roemer & 
Krysan 2014). Poor prognosis for patients with various systemic mycoses such as 
invasive candidiasis (Kullberg & Maiken 2015) and invasive aspergillosis (Taccone 
et al 2014) highlight the need to develop more effective treatments (Souza & Amaral 
2017). As the discovery of new antifungals has been slow over the last 50 years, it 
may be more feasible to improve drug delivery of current antifungal medicines than 
to discover new ones. The antifungal with the broadest spectrum for treating 
systemic fungal infections is the polyene macrolide antibiotic, amphotericin B, which 
has been used in medical practice for over 50 years (Bartner et al 1957). The broad 
spectrum of this drug despite side effects and its continued effectiveness after more 
than a half-century of clinical use, means that improvements of its delivery may 
improve its tolerance and outcomes for patients with various systemic fungal 
infections for years to come. 
 
Amphotericin B is a natural product produced by Streptomyces nodosus. The 
amphotericin B molecule has a mycosamine group attached to a 38 membered ring 
that has seven conjugated double bonds and multiple electronegative hydroxyl 
groups (Fig. 1.1). The amphotericin B molecule has characteristic wavelengths 
detectable by UV-Vis spectrophotometry (McNamara et al 1998, Singh et al 2014). 
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Figure 1.1 The macrolide structure of amphotericin B. The molecular structure of 
amphotericin B showing a large macrocyclic polyene lactone ring attached to a 
sugar. 
 
Amphotericin B is produced via a type I polyketide synthase (PKS) system (Caffrey 
et al 2001, Chuck et al 2006). Multifunctional proteins drive the sequential 
condensation of three propionate and sixteen acetate units to form an intermediate 
polyketide ring that is modified by cytochrome P450 and glycosyl transferase 
enzymes to yield amphotericin B (Caffrey et al 2001). The role of PKS genes for 
amphotericin B biosynthesis was confirmed in our laboratory by disrupting one of 
the PKS genes with a hygromycin resistance cassete to create the knockout mutant, 
S. nodosus MAΩhyg, that does not produce amphotericin B (Nikodinovic 2004, 
Pereira et al 2008).  
 
There are several models to explain the mode of action amphotericin B in fungal 
membranes. The classical model is via the formation of ion channels.  In this model, 
aggregates of amphotericin B bind to ergosterol in the fungal lipid membrane 
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creating an electronegative pore through which essential K+ ions are lost leading to 
destruction of the organism (Mouri et al 2008). Other models have been proposed 
including a surface adsorption model and a sterol sponge model (Anderson et al 
2014). 
 
IN clinical use in humans amphotericin B can have severe side effects. The 
macrolide polyene structure of amphotericin B is poorly soluble in water, and in 
aqueous media can readily form micelles which are problematic for drug delivery 
(Kawabata et al 2001). While having a higher affinity for ergosterols in fungal 
membranes, amphotericin B also binds to cholesterol in human cells, which is 
thought to contribute to the high rates of nephrotoxicity (Kamiński 2014). Some 
work has been done on producing synthetic analogues with reduced affinity for 
binding with cholesterol, such as C2' deoxyamphotericin B (Wilcock et al 2013). 
Improvements in the solubility and delivery of amphotericin B have also been 
achieved through the use of liposomes. 
 
Liposomes are artificial vesicles, phospholipid membranes containing molecular 
cargo, used in the delivery of hydrophobic drugs.  A liposomal formulation of 
amphotericin B called AmBisome improves the solubility of amphotericin B and 
causes reduced rates of nephrotoxicity compared to traditional formulations (Adler-
Moore 1994). Amphotericin B co-localises with the vesicle membrane of AmBisome 
and has also been shown to co-localise with the vesicle membrane of giant 
unilammelar liposomes (Grudzinski et al 2016). The association of amphotericin B 
with phospholipid membranes suggests a similar phenomenon may occur within the 
phospholipid membranes of extracellular vesicles (EVs) produced by S. nodosus. 
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1.2 Natural extracellular vesicles 
Organisms across the three domains of life produce EVs (Deatherage & Cookson 
2012) and utilise them for diverse processes including predation of microbial 
competitors (Evan et al 2012), communication (Mashburn & Whitely 2005, Tashiro 
et al 2010), transport of nucleic acids (Blesa & Berenguer 2015, Das & Halushka 
2015) and the delivery of toxins into the extracellular environment (Prangishvili et al 
2000). EVs may also function to protect molecules from oxidation as seen in Frankia 
sp. (Ghodhbane-Gtari et al 2014). 
 
Natural EVs have potential in the delivery of therapeutic molecules (Meel et al 2014) 
and have successfully been used as novel vehicles for therapeutic drug delivery of 
nucleic acids (Andaloussi et al 2013). As Streptomyces have adapted for life in the 
soil alongside fungi, an EV delivery system of amphotericin B may preferentially 
target mycotic infections over human cells, reducing side effects and leading to 
improved patient outcomes. There is currently a lack of evidence demonstrating that 
S. nodosus produces EVs, although other Streptomyces species have been shown to 
produce EVs that are packed with polyketide antibiotics (Schrempf et al 2011, 
Schrempf & Merling 2015). 
 
For many years it had been noted that some Streptomyces develop droplets on the 
surface of hydrophobic aerial hyphae on solid culture. Recently it was shown that 
S. coelicolor produced droplets containing high quantities of EVs with high protein 
content (~1 to 2 µg µL-1) and densely packed with molecules for secretion including 
the polyketide antibiotic, actinorhodin (Schrempf et al 2011). Similarly, droplets that 
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form on the surface of S. lividans cultures also are a rich source of EVs that package 
the polyketide antibiotic undecylprodigiosin and have high protein content (~1 to 2 
µg µL-1) (Schrempf & Merling 2015). The discovery of EVs in droplet exudates 
produced by S. coelicolor and S. lividans suggests that droplets produced by other 
Streptomyces species may also be novel sources of Streptomyces EVs. Unfortunately, 
S. nodosus does not produce droplets on solid media. This means to investigate 
delivery mechanisms, alternate methods need to be used to isolate EVs from liquid 
media. EVs from this source are expected to be more dilute than EVs in droplets. 
Size fractionation techniques have been used to isolate EVs from culture broth of 
Gram positive organisms (Chutkan et al 2013) and could be employed to isolate S. 
nodosus EVs. 
 
Image analysis is important for the characterisation of EVs . EVs from S. coelicolor 
and S. lividans discussed previously were imaged with TEM. TEM is a common 
technique for imaging EVs in other organisms and samples are often treated with a 
negative stain, like phosphotungstic acid or osmium tetroxide (Mielańczyk et al 
2015). As TEM facilities were not available at the university other techniques were 
considered. An alternative technique to TEM for the imaging of EVs was scanning 
transmission electron microscopy (STEM), which was readily available at the 
university. While STEM has been used to image EVs (Burlaud-Gaillard et al 2014) 
use of the technique for imaging EVs is not well known and was not included in a 
recent review of the techniques available for  EV detection and characterisation 
(Nawaz et al 2014).  
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1.3 Aims  
This research aimed to gain insights into the role of S. nodosus EVs for amphotericin 
B delivery once image techniques were developed. A previously unidentified 
Streptomyces strain, S. "purple", was used as a reproducible source of vesicles for 
this endeavour and was identified as part of this project. These techniques were used 
to show S. nodosus produces EVs. For STEM analysis, EVs were isolated from 
S. nodosus culture broth using size fractionation techniques. TEM facilities at 
Macquarie University were also used to image S. nodosus EVs and comparisons 
between the TEM and STEM micrographs used to assess the suitability of STEM for 
imaging EVs. STEM was also used to analyse S. nodosus MAΩhyg culture broth 
extracts for EVs to determine whether the mutant produced EVs. Later stages of the 
project indicated co-localisation of amphotericin B with S. nodosus EVs by UV-Vis 
spectroscopy and STEM analysis.  
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CHAPTER 2 
 
MATERIALS AND METHODS  
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2.1 Materials 
2.1.1 Bacterial strains 
Streptomyces nodosus wildtype (ATCC 14899) was obtained American Type Culture 
Collection and maintained as spore suspensions in 20% (v/v) glycerol held at -80 °C. 
S. nodosus MAΩhyg, a mutant strain that does not produce amphotericin B, was 
made previously in our lab (Nikodinovic 2004, Pereira et al 2008) and maintained as 
20% (v/v) glycerol spore suspensions held at -20 °C. The uncharacterised strain 
designated S. "purple" was isolated previously by our group from soil gathered from 
Western Sydney University's North Parramatta campus (Chuck, unpublished data) 
and maintained as spore suspensions in H2O at -20 °C. 
 
2.1.2 Reagents and media components 
Bacteriological Agar, Yeast Extract and Malt Extract were from Oxoid. Glycerol, 
L-asparagine and α-D-glucose were purchased from Sigma-Aldrich. Salts 
(K2HPO4.3H2O, FeSO4.7H2O, MnCl2.4H2O, ZnSO4.7H2O) were from Univar.  
  
Primers for the amplification of the Streptomyces 16S RNA sequence 16Sforwhole 
(5' GGGAAGCTTCACGGAGAGTTTGATCCT 3')  and 16Srevwhole (5' 
CCCTCTAGAAAGGAGGTGATCCAGC 3') were synthesised by Sigma-Genosys 
and had been designed previously using conserved regions of rDNA in the 
S. ambofaciens sequence (Pernodet et al 1989).  
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2.2 Growth of Streptomyces cultures 
2.2.1 Growth S. "purple" on solid media 
Glycerol-asparagine agar (GA) (20 g L-1 bacteriological agar, 10 g L-1  glycerol, 1.3 g 
L-1  K2HPO4.3H2O, 1 g L
-1  L-asparagine,  10 mg L-1 FeSO4.7H2O, 10 mg L
-1 
ZnSO4.7H2O, 10 mg L
-1, MnCl2.4H2O) (Shirling and Gottlieb 1966) was used for the 
growth of S. "purple" on solid media. Spore suspensions of S. "purple" (1 µL) were 
germinated on GA agar at 30 °C for 7 days after which mycelial growth with 
sporulation was evident. Spores of the organism were subcultured onto GA agar and 
incubated at 30 °C for 3 days until droplets were visible by the naked eye on the 
surface of the biomass. 
 
2.2.2 Growth of Streptomyces strains in liquid media 
Growth of S. "purple" and S. nodosus strains in liquid media were carried out in 250 
mL or 1 L baffled flasks containing 30 mL or 125 mL yeast malt glucose (YMG) 
liquid broth (4 g L-1 yeast extract, 10 g L-1 malt extract, 4 g L-1 α-D-glucose), 
respectively. Spore suspensions (50-100 µL) of the Streptomyces strains were used to 
inoculate the liquid media and cultivated with shaking (200 rpm) at 30 °C for 3-10 
days. 
 
2.3 Identification of the soil derived S. "purple" 
2.3.1 Isolation of S. "purple" gDNA 
The isolation of gDNA from S. "purple" was performed following methods 
previously developed by our research group (Nikodinovic et al 2003). Streptomyces 
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"purple" spore suspension (50 µL) was used to inoculate baffled flasks containing 
YMG liquid media and incubated for 4 days as described in section 2.2.2. The 
culture biomass was harvested by removal of the supernatant after centrifugation 
(4500x g, 25 °C, 10 min). The pellets were resuspended in lysis solution (10 mL, 0.3 
M sucrose, 25 mM EDTA, 25 mM Tris-HCl, 4 U RNase, pH 7.3). Lysozyme (10 
mg), and achromopeptidase (5 mg) were added before incubating (37 °C, 20 min). 
SDS (1 mL, 10% w/v) and proteinase K (5 mg) were added before further incubation 
with shaking (55 °C, 150 rpm, 90 min). NaCl (3.6 mL, 5 M) and chloroform (15 mL) 
were added to the tubes before rotating them end over end (20 min). The aqueous 
phase of the samples was transferred to clean tubes after centrifugation (4500x g, 
25 °C, 30 min). DNA was precipitated from the aqueous phase by addition of 
isopropyl alcohol (1 volume) before centrifugation (4500x g, 25 °C, 30 min). The 
supernatant was removed leaving a DNA pellet, to which ethanol was added (1 mL, 
70% w/v, 1 min). The ethanol was removed and the DNA pellet allowed to air dry (1 
h) before dissolving in DNA buffer (100-200 µL, 60 °C, 10 mM Tris HCl, 10 mM 
EDTA, pH 7.4) and storing in the freezer (-20 °C).  
 
The sizes of gDNA were investigated with electrophoresis and nucleic acid 
concentration and DNA purity was quantitated using UV-Vis spectrophotometry as 
described in section 2.3.3. gDNA previously isolated from S. neyagawaensis was 
available in our lab and was loaded on the gel for size comparison. 
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2.3.2 Polymerase chain reaction 
Polymerase chain reaction (PCR) was performed using the isolated gDNA of 
S. "purple" as a template to amplify the 16S rDNA using the primers 16Sforwhole 
and 16Srevwhole. Reactions contained 10 pmol of each primer, 5 ng template DNA, 
12.5 µL AmpliTaq Gold® 360 Master Mix (Invitrogen), 0-5 µL GC enhancer 
(Invitrogen), and water to a total volume of 25 µL. PCR conditions were 97 °C for 
30 s (denaturation), 50 °C  for 1 min (annealing) and 72 °C for 1 min (extension) for 
30 cycles using a PTC-100 Programmable Thermal Controller (MJ Research Inc.). 
PCR products were analysed and purified as described in section 2.3.3. 
 
2.3.3 DNA analysis and purification 
DNA was separated by electrophoresis (70 V, 1 h) on agarose gels (1% (w/v) in 1 x 
TAE) using 1 x TAE running buffer containing 0.5 mg L-1 EtBr. Gels were 
visualised by UV light using a Gel Doc EZ-Imager (BioRad). All DNA quantitation 
was performed using a NanoDrop 2000C UV-Vis spectrophotometer 
(ThermoScientific). A Purelink Quick Gel Extraction & PCR Purification Combo Kit 
(Invitrogen) was used to extract and purify 16S PCR products excised from a 1% 
(w/v) agarose gel in TAE. Purified PCR products were visualised and quantitated as 
described above. The Australian Genomic Research Facility’s (Westmead, Australia) 
Sanger sequencing service was used for sequencing of the purified PCR products 
from S. "purple" with either primer 16Sforwhole or 16Srevwhole.  
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2.3.4 Bioinformatic analysis of  sequenced DNA 
Unreliable base reads in the raw forward and reverse 16S rDNA sequences of 
S. "purple" (Appendix 1) were coded as missing data. Combined forward and reverse 
read length of the S. "purple" sequences were shorter than other 16S rDNA 
sequences of Streptomyces, therefore these were aligned to other 16S rDNA 
sequences with a segment of missing data between the forward and reverse. The 
DeNovo assembly tool in Geneious software was used to generate a 1454 bp 16S 
rDNA sequence of S. "purple" by inserting N nucleotides between the aligned 
forward and reverse sequences of S. "purple" (Appendix 2). The S. "purple" 16S 
sequence was aligned with 16S sequences of the 115 Streptomyces species, 2 
Kitasatospora species and Mycobacterium tuberculosis (Appendix 3), which was 
added as an out-group. A maximum likelihood phylogeny was generated using 
IQ-Tree (Nguyen et al 2015) using the ultrafast bootstrap approximation (Minh et al 
2013) with 1000 resamplings.  
 
2.4 Imaging Streptomyces extracellular vesicles 
2.4.1 Isolation of samples for EM analysis 
Streptomyces "purple" was grown on solid medium as outlined in section 2.2.1. 
Droplet exudates that formed on subcultured colonies were collected by placing the 
copper side of carbon coated copper TEM grids (300 mesh, ProSciTech) to the 
surface of the droplets. Samples were processed as outlined in section 2.4.2.  
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S. nodosus and S. nodosus MAΩhyg were grown in 30 mL YMG media for 7 days as 
outlined in section 2.2.2. Cell debris in the liquid broths was removed via 
centrifugation (15,000x g, 25 °C, 15 min) and the supernatant filtered through a 
syringe driven 0.22 µm filter unit (Millex). The filtered supernatant was added to a 
100 kDa molecular weight cut off centrifugal filter device (Amicon) and centrifuged 
(7500x g, 25 °C, 20 min). The filtrate (<100 kDa) of S. nodosus was collected and set 
aside for preparation on TEM grids as a control. The filter devices were inverted and 
centrifuged (1000x g, 25 °C, 2 min) into a recovery tube to collect the >100 kDa 
fraction. 
 
2.4.2 Sample preparation for EM imaging 
The following procedure was conducted in a biosafety cabinet on parafilm. Droplet 
exudates of S. "purple", the >100 kDa fraction of S. nodosus culture broth (2 µL), S. 
nodosus MAΩhyg culture broth (2 µL), and the <100 kDa filtrate of S. nodosus 
culture broth (2 µL) were added to the copper side of C coated Cu TEM grids and 
allowed to stand (5 min) at room temperature. The grids were transferred into 
glutaraldehyde (3% w/v in phosphate buffer pH 7.2, 200 µL, 15 min) to fix the 
vesicles. The excess liquid was removed by blotting and the grids were transferred 
into negative stain, phosphotungstic acid (3% w/v, 300 µL, 1 min). The liquid was 
removed by blotting and the grids moved into drops of deionised water (200 µL, 5 
min). The water was removed by blotting and grids allowed to air dry in the hood (60 
min) before being stored in a TEM grid box in preparation for imaging.   
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2.4.3 EM analysis 
The samples on TEM grids were investigated by STEM for the presence and 
morphology of extracellular vesicles using a JEOL 7001F SEM equipped with a 
TED detector in STEM mode at the Advanced Materials Characterisation Facility, 
Western Sydney University. STEM images were taken in bright field using a 
working distance of 10 mm, a probe current of 0.8 A and an electron beam voltages 
of 15-30 kV.  
 
The >100 kDa fraction of S. nodosus culture broth was imaged as a control using a 
Phillips CM10 TEM with an Olympus SIS megaview G2 Digital camera at the 
Microscopy Unit, Macquarie University. TEM images were taken in bright field 
using an electron voltage of 100 kV. 
 
2.5 UV-Vis spectroscopy of culture fluid extracts of S. nodosus strains  
2.5.1 Amphotericin B detection in wildtype and mutant S. nodosus culture broth 
extracts 
Spore suspensions of S. nodosus (50 µL) and S. nodosus MAΩhyg (50 µL) were 
cultivated in either 30 mL or 125 mL of YMG media for 3-10 days as outlined in 
section 2.2.2. A cell free supernatant was obtained after centrifugation (4500 x g, 
25 °C, 10 min) and removal of the biomass pellet. Samples were prepared for 
amphotericin B analysis with the addition of DMSO (1 volume), vortexing (5 min) 
and centrifugation (4500x g, 25 °C, 10 min). The supernatants were diluted 10 fold 
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with 100% (v/v) methanol and vortexed (1 min) before recording the UV-Vis spectra 
(250-500 nm) using a Cary-100 series UV-Vis spectrophotometer (Agilent). 
 
2.5.2 Size fractionation and UV-Vis analysis of S. nodosus culture broth extracts 
In some experiments, wildtype S. nodosus culture broths were further clarified by 
passing the cell-free broths through a 0.22 µM syringe filter unit (Millex) to further 
remove any remaining biomass. The filtrate (2 mL) was size fractionated into >100 
kDa and <100 kDa fractions as described in section 2.4.1. The < 100 kDa fraction 
and the clarified culture broth it was obtained from were further analysed for the 
presence of amphotericin B as described in section 2.5.1. 
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CHAPTER 3 
 
RESULTS  
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3.1 Taxonomic identification of S. "purple" 
As there was a need to develop in house methods for imaging vesicles of 
Streptomyces species, a reliable source of concentrated EVs was required. None of 
the characterised organisms in our laboratory maintained the phenotype for droplet 
production on repeated subculturing. In contrast, an uncharacterised soil isolate 
assumed to be a Streptomyces strain produced droplets on repeated sub-culture. The 
organism produced pigments secreted into solid media, had an earthy odour, and 
colony morphology that undergoes differentiation into sporulating aerial hyphae, all 
of which are characteristic of Streptomyces species. The droplets and pigment 
secreted by the soil isolate were a striking purple colour when grown on GA agar 
solid media (Fig. 3.1), and so the isolate was designated the "in-house" name 
Streptomyces "purple". To ensure the organism belonged to the Streptomyces genus, 
experiments to identify S. "purple"  taxonomically were undertaken using molecular 
biology and phylogenetic techniques.  
 
Figure 3.1 Purple droplets on colonies of S. "purple". Scale bar = 1 mm 
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3.1.1 Isolation of gDNA   
gDNA was successfully isolated from S. "purple" using methods previously 
developed by our research group. Agarose gel electrophoresis showed  DNA present 
of sizes >10 kb for the isolated gDNA of S. "purple" (Fig. 3.2 Lanes D - H). The size 
of gDNA products also aligned with a gDNA band from the gDNA of 
S. neyagawaensis (Fig. 3.2 Lane B). The broad, bright bands observed at the bottom 
of the gel for all of our samples indicated that the samples contained some RNA.  
 
 
Figure 3.2: Agarose gel electrophoresis of Streptomyces gDNA.  (Lane A) : 1 kb 
step ladder (Promega). (Lane B) : gDNA from S. neyagawaensis. (Lane C) : DNA 
isolation buffer. (Lanes D - H) : S. "purple" gDNA. 
 
Quantitation via UV-Vis analysis of the gDNA samples showed nucleic acid 
concentrations ranging from 752 ng µL-1 to 3052 ng µL-1 (Table 3.1). A260/280 
values ranging from 1.82-2.13 indicated samples contained DNA and some RNA. 
RNA 
>10 kb 
10 kb 
  A       B       C        D       E        F       G       H   
2 kb 
1 kb 
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The sample with an A260/280 value of 1.82 was deemed to have acceptable DNA 
quality and was used for subsequent PCR reactions. 
 
Table 3.1: A260/280 ratios and concentration of S. "purple" gDNA isolates 
Sample Nucleic acid concentration (ng µL-1) A260/280 
1 1226 1.82 
2 1065 2.10 
3 864 2.13 
4 752 2.11 
5 3052 2.07 
 
 
3.1.2 PCR 
The gDNA isolated from S. "purple"  was used as template DNA to generate 16S 
rDNA PCR products for sequencing. PCR products were analysed using 
electrophoresis with the resulting agarose gel showing 16S PCR products of size    
~1.5 kb (Fig. 3.3 Lanes B, C, D, E, G, H). Some minor optimisation showed the PCR 
reactions containing 10 ng template DNA and no GC enhancer had the brightest 
bands on the gel (Fig. 3.3 Lanes D, E). In contrast, products of PCR reactions that 
contained 5 ng template DNA and 0-1 µL GC enhancer produced well defined bands 
on the gel (Fig. 3.3 Lanes B, C, H, I), while the PCR products of reactions containing 
5 ng template DNA and 5 µL GC enhancer showed either no bands (Fig. 3.3 Lane F) 
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or a very faint band (Fig. 3.3 Lane G). These results indicated that having an 
increased amount of template DNA was favourable for the PCR reactions.  
 
 
Figure 3.3: Agarose gel of 16S PCR products of S. "purple". (Lanes A and L) : 
1kb step ladder (Promega). (Lanes B and C) : Products of PCR containing 0 µL GC 
enhancer and 5 ng gDNA template showing ~1.5 kb bands. (Lanes D and E) : 
Products of PCR containing 0 µL GC enhancer and 10 ng gDNA template showing 
bright ~1.5 kb bands. (Lanes F and G) : Products of PCR containing 5 µL GC 
enhancer and 5 ng gDNA template showing ~1.5 kb bands. (Lanes H and I): 
Products of PCR containing 1 µL GC enhancer and 5 ng gDNA template showing 
~1.5 kb bands. (Lanes J and K) : Negative controls missing either a forward or 
reverse primer showing no bands . Primer dimers observed for successful PCR 
reactions at the end of gel. 
2 kb 
1 kb 
Primer dimers 
~1.5 kb 
A    B    C   D   E   F    G    H   I     J   K    L 
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The negative controls showed no bands (Fig. 3.3 Lanes J, K) which was expected as 
the reactions for these products were missing one of either primer 16Sforwhole or 
16Srevwhole. A broad band at the end of the gel was observed for all successful PCR 
products, which were suspected to be primer dimers. The resolution of the ladder was 
fairly poor prompting the purchasing of a new ladder (Fig. 3.3 Lanes A, L). 
 
3.1.3 Gel purification 
PCR reactions that showed well defined bands of sizes approx. 1.5 kb were pooled 
and run on a preparative 1% agarose gel. The 1.5 kb band was purified from the gel 
and the two resulting samples were checked by electrophoresis and quantitated by 
UV-Vis analysis.  
 
The purification process was verified by analytical electrophoresis showing very 
faint bands of sizes ~1.5 kb (Fig. 3.4 Lanes B, C). The negative control (Fig. 3.4 
Lane D) had a very faint band from carry over sample that occurred during loading. 
The unpurified product was also loaded for comparison showing a ~1.5 kb band and 
a primer dimer band at the end of the gel (Fig. 3.4 Lane E).  
 
PCR products extracted from the preparative gel were quantitated with UV-Vis 
(Table 3.2). While these products showed no primer dimer bands after 
electrophoresis (Fig. 3.4 Lanes B, C), their A260/280 ratios were > 2 which indicated 
they may be contaminated with RNA. A decision was made to continue using these 
PCR products to generate a 16S rDNA sequence of S. "purple". Nucleic acid 
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concentration of the products were at the lower limit required for sequencing (3.5 ng 
µL-1 and 2.7 ng µL-1, Table 3.2). 
 
 
Figure 3.4: Purified PCR products gel. (Lane A) : Direct load 1kb DNA ladder 
(Sigma-Aldrich). (Lanes B and C) : Purified PCR products. (Lane D) : elution buffer. 
(Lane E) : unpurified PCR product. (Lane F) : 1kb step ladder (Promega). 
 
Table 3.2: A260/280 values and concentration and of purified 16S rDNA PCR 
products from S. "purple" 
S. "purple" 16S rDNA Nucleic acid conc. (ng µL-1) A260/280 
Sample 1 3.5 2.35 
Sample 2 2.7 2.13 
 
 A      B        C       D       E       F  
Primer dimer 
1.5 kb 
2 kb 
1 kb 
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3.1.4 Sequencing  
Two template samples were submitted for sequencing using the forward and reverse 
primers, yielding four sequencing results. A 556 bp forward sequence and a 672 bp 
reverse sequence were obtained for one of the samples while a 430 bp forward 
sequence and a 844 bp reverse sequence were obtained for the other sample (Table 
3.3, Appendix 1). The forward and reverse sequences of the first sample both had 
<100 (<20%) Q20 bases detected, while the forward and reverse sequences of the 
other sample had 408 (95%) and 683 (81%) Q20 bases detected respectively (Table 
3.3).  
 
Table 3.3: Raw sequence length and Q20 bases of S. "purple" rDNA sequences 
 
 
Sample Tube Raw Sequence length 
(bp) 
Q20 bases 
(bp) 
Q20 bases 
(%) 
Purified 16S sample 1 
+ 16Sforwhole 
556 95 17 
Purified 16S sample 1 
+ 16Srevwhole 
672 89 13 
Purified 16S sample 2 
+ 16Sforwhole 
430 408 95 
Purified 16S sample 2 
+ 16Srevwhole 
844 683 81 
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The sequences from sample 2 were determined to be more reliable than the 
sequences of sample 1 via their respective Q20 base scores and so were used in the 
assembly of a 1454 bp 16S rDNA sequence of S. "purple" (Appendix 6.2). The 1454 
bp 16S rDNA sequence of S. "purple" was aligned with 115 other Streptomyces 
species, 2 Kitasatospora species and M. tuberculosis (Appendix 6.3) and a 
phylogenetic tree was constructed. 
 
3.1.5 Phylogenetic analysis of 16S rDNA isolated from S. "purple" 
The phylogenetic tree, including S. “purple”, 115 other Streptomyces species, 2 
Kitasatospora species and M. tuberculosis (Fig. 3.5), placed S. "purple" in the  
S. violaceoruber clade with greater than 95% bootstrap support. This clade also 
includes several other species such as S. violaceoruber, S. violaceolatus, 
S. humiferus, S. fragilis, S. coelicoflavus, S. anthocyanicus, S. tricolor and 
S. coelescens.  
 
The relationship between members of other established Streptomyces clades is also 
shown. Streptomyces albidoflavus, S. coelicolor, S. champvatii and S. sampsoni were 
grouped together in the S. albidoflavus clade with 99% bootstrap support. 
Streptomyces griseus, S. microflavus, S. alboviridis, S. anulatus and S. acrimycini 
were grouped together in the S. griseus clade with 99% bootstrap support.  
 
The two members of the Kitasatospora genus, K. atroaurantica and K. mediocidica, 
were grouped together with 100% bootstrap support. Kitasatospora was nested 
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within Streptomyces with 96% bootstrap support indicating Streptomyces is 
paraphyletic.  
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Figure 3.5 Phylogenetic tree (continued on following page) obtained by ML 
analysis based on 6S sequences. Values at nodes are bootstrap support 
approximations from the maximum likelihood analysis  
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3.2 Development of methods for imaging S. "purple" vesicles 
Having determined that S. "purple" was a Streptomyces strain, the availability of a 
reliable source of droplets in the laboratory allowed for development of methods for 
EV image analyses. Imaging of Streptomyces vesicles in the literature has been 
performed using TEM, however these facilities were not readily available or easily 
accessible compared with STEM facilities. Methods were developed to image 
Streptomyces vesicles with STEM using droplets produced by S. "purple" as a source 
of vesicles.  
 
STEM was successfully used to image extracellular vesicles in droplets produced by 
S. "purple" (Fig. 3.6) though optimisation was required. Images taken at 15 kV only 
showed black structures (Fig. 3.6A), indicating the electron beam was not 
penetrating the sample and reaching the TED detector. A higher contrast was 
observed when the electron beam voltage was increased to 25 kV, revealing a 
number of spherical structures with a dark centre and bright outside ring (Fig. 3.6B)  
that was consistent with other EVs imaged with STEM (Fig. 3.6C) (Burlaud-Gaillard 
et al 2014), and Streptomyces EVs imaged with TEM (Fig. 3.6D) (Schrempf & 
Merling 2015). 
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Figure 3.6 STEM images of droplet exudates produced by S. "purple". 
(A): Numerous spherical dark structures of sizes ~60 - 120 nm observed at 15 kV. 
(B): Numerous spherical structures of sizes ~60 - 120 nm with internal contrast 
showing dark centres surrounded by a bright ring observed at 25 kV.  (C): STEM 
image of EVs in literature (Burlaud-Gaillard et al 2014). (D) TEM image of 
Streptomyces EVs in literature (Schrempf & Merling 2015). Scale bars: 100 nm 
 
3.3 Imaging of vesicles from S. nodosus strains 
Following the development of methods for imaging Streptomyces EVs with STEM, 
experiments were undertaken to see if EVs were produced in liquid cultures from 
wildtype S. nodosus and S. nodosus MAΩhyg, a mutant strain deficient in 
amphotericin B production. Biomass was crudely separated from culture fluid by size 
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fractionation and prepared on grids for analysis with STEM. As the S. "purple" 
STEM images showed more contrast with a higher electron beam voltage, STEM 
imaging of S. nodosus and S. nodosus MAΩhyg culture fluid extracts was performed 
using the highest possible electron beam voltage (30 kV) offered by the JEOL-7001F 
SEM when operating in STEM mode.  
 
EVs of various sizes were observed with STEM in both the S. nodosus (Fig. 3.7) and 
S. nodosus MAΩhyg (Fig. 3.8) >100 kDa size fractionated samples, appearing as 
dark circles with a light ring near the edge. There was no significant size or 
morphology differences between the vesicles of S. nodosus (27-151 nm) and vesicles 
of S. nodosus MAΩhyg (35-163 nm), with S. nodosus having a mean vesicle 
diameter and standard deviation of 84 ± 33 nm (n=22) and the mutant having an 
average vesicle diameter and standard deviation of 84 ± 33 nm (n=26) (Appendix 
6.4). EVs were not detected in the <100 kDa fraction of S. nodosus culture broth 
(data not shown). 
 
A >100 kDa fraction of S. nodosus culture broth was also analysed by TEM for 
comparison of image quality generated by STEM and EVs were observed (Fig. 3.9). 
The EVs observed with TEM were much brighter than S. nodosus EVs imaged with 
STEM (Fig. 3.7), however the TEM image had poorer resolution. 
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Figure 3.7: STEM analysis of a >100 kDa fraction of wildtype S. nodosus culture 
broth. (A - F):  Numerous spherical EVs of various sizes (~30 - 150 nm). Scale 
bars: 100 nm in A - D; 10 nm in E and F. 
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Figure 3.8: STEM analysis of a >100 kDa fraction of S. nodosus MAΩhyg 
culture broth. (A-D): Numerous spherical EVs of various sizes (~30 - 160 nm). 
Scale bars: 100 nm.  
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Figure 3.9: TEM analysis of a >100 kDa fraction of S. nodosus culture broth. 
Spherical EVs of sizes ~50 nm appearing as circles with a bright outside ring. Scale 
bar :200 nm. 
 
3.4 Co-localisation of amphotericin B with EVs of S. nodosus strains 
3.4.1 Confirming production of amphotericin B by the S. nodosus strains 
UV-Vis spectroscopy was used to analyse samples extracted from the culture broth 
of S. nodosus and S. nodosus MAΩhyg with DMSO and methanol to confirm 
production of amphotericin B by the wildtype S. nodosus strain. The UV-Vis spectra 
of the wildtype S. nodosus culture fluid extract (Fig. 3.10) showed strong peaks at 
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Figure 3.10 UV-Vis spectra (500-250 nm) of a culture broth extract from 
wildtype S. nodosus. Shifts were detected at 345 nm, 361 nm, 382 nm and 406 nm 
indicating the production of amphotericin B by the wildtype strain. 
 
 
Figure 3.11 UV spectra (500-250 nm) of a culture broth extract from S. nodosus 
MAΩhyg. No major peaks were observed indicating amphotericin B was not being 
produced by the mutant strain. 
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345 nm, 361 nm, 382nm and 406 nm which are consistent with amphotericin B 
(McNamara et al 1998) indicating the wildtype S. nodosus strain was producing 
amphotericin B.  
 
In contrast the UV-Vis analysis of the S. nodosus MAΩhyg extract (negative control, 
Fig. 3.11) showed the spectra had no major peaks which indicated the mutant was 
not producing amphotericin B.  
 
3.4.2 Co-localisation of amphotericin B in size fractionated S. nodosus  culture 
broth extracts 
UV-Vis spectroscopy was also used to investigate whether EVs produced by 
S. nodosus and amphotericin B co-localised during size fractionation. As STEM 
investigations had shown a <100 kDa fraction of S. nodosus culture broth was free of 
EVs, it was hypothesised that the fraction would have a low concentration of 
amphotericin B if amphotericin B was associated with EVs. A cell free culture broth  
was passed through a 100 kDa molecular weight cut off filter device to obtain a <100 
kDa filtrate. Equal volumes of the cell-free culture broth and the <100 kDa fraction 
were analysed for amphotericin B content using UV-Vis spectroscopy (500-250 nm). 
 
The UV-Vis spectra of the cell free S. nodosus culture broth showed peaks at 343 
nm, 368 nm, 382 nm and 406 nm (Fig. 3.12). These peaks are very similar to the 
predicted amphotericin B shifts at 346 nm, 364 nm, 382 nm and 405 nm (McNamara 
et al 1998). In contrast the spectra of the <100 kDa fraction had no major peaks, 
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although small peaks at 342 nm and 368nm were detected. The peak at 342 nm could 
be an artefact similar to the one seen for S. nodosus MAΩhyg (Fig. 3.11). The small 
shift at 368 nm for the <100 kDa fraction (Fig. 3.12) was also observed in all other 
UV-Vis spectra (Fig. 3.10, 3.11) which indicated these shifts were noise. 
Furthermore, the existence of this noise indicated that the observed shift for 
S. nodosus culture broth (Fig. 3.11) at 368 nm could also be noise, giving rise to the 
possibility of a masked peak at 364 nm, as is characteristic of one of the four signals 
corresponding with amphotericin B. 
 
 
Figure 3.12: UV spectra (500-250 nm) of S. nodosus culture broth extracts. 
(Black) : S. nodosus culture broth extract showing peaks at 343 nm 368 nm 382 nm 
and 406 nm indicating the presence of amphotericin B. (Red) : A <100 kDa fraction 
of the S. nodosus culture broth extract showing no major peaks. 
 
The UV-Vis spectra of these two samples (Fig. 3.12) indicated that the removal of 
vesicles and other >100 kDa content by size fractionation from S. nodosus culture 
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broth significantly reduced or eliminated amphotericin B concentration in the broth. 
This result suggests that S. nodosus co-localises amphotericin B in EVs.  
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CHAPTER 4  
 
DISCUSSION  
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Drug delivery is an important area of pharmacological research because despite a 
drug having bioactivity, its administration in the human body can be problematic 
(Mitragotri et al 2014). As outlined previously, amphotericin B has been packaged 
into liposomes to circumvent toxicity issues (Adler-Moore 1994), some of which 
have been attributed to insolubility due to the drug's hydrophobicity (Liu et al 2017). 
This project investigated how S. nodosus addresses this issue. As the natural 
producer of this drug, the organism excretes the drug into an aqueous environment 
and must have developed mechanisms to do so. From studying this model, insight 
into how nature has evolved to solve this problem may provide information to be 
used in the pharmacology industry. 
 
EVs are being explored as a mechanism for distribution of biomolecules into 
complex environments in nature and medicine (Brown et al 2015, Schwechheimer & 
Kuehn 2015). By using EV delivery systems hydrophobicity issues could be 
overcome, protection from chemical and biotic degradation could occur and targeted 
delivery of contents may be possible. All these issues are important aspects of drug 
delivery (Mitragotri et al 2014). Before analysing amphotericin B delivery via 
vesicles, methods needed to be developed and established in our laboratory. 
 
4.1 Taxonomy of S. "purple" -  a model organism for development of vesicle 
imaging techniques 
Streptomyces "purple" had been shown to produce extracellular droplets on the 
surface of mycelia on repeated subculture, while other organisms in our laboratory 
lost this capacity (Chuck, unpublished data). As Streptomyces droplets have been 
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shown to be a novel source of vesicles (Schrempf  et al 2011, Schrempf & Merling 
2015) it was decided to use droplets produced by S. "purple" as a model to develop 
vesicle imaging techniques. At the beginning of the project there was limited 
evidence that the organism was a Streptomyces species, so concurrently with 
developing imaging methodology, taxonomic experiments were undertaken. To this 
end, gDNA was isolated from S. "purple" and PCR used to amplify the 16S rDNA 
sequence for phylogenetic analysis. The 16S rDNA sequence is highly conserved 
amongst bacteria and is widely used for taxonomic evaluation of these organisms 
(Srinivasan et al 2015). 
 
The observed sizes (>10 kb) of S. "purple" gDNA by electrophoresis were consistent 
with sizes of gDNA isolated from other Streptomyces species using the same 
technique that were >30 kb (Nikodinovic et al 2003). While the gDNA isolation of 
S. "purple" and subsequent PCR reactions were successful, poor purification yield of 
the 16S rDNA products and high A260/280 ratios were observed, however 
sequenced data was still obtained. This may have caused the sequences to be shorter 
than expected. Fortunately the region containing the majority of missing nucleotides 
in the 1454 bp 16S rDNA sequence of S. "purple" is fairly well conserved amongst 
the other Streptomyces and Kitasatospora species used in the construction of the 
phylogenetic tree.  
 
Through the construction of a phylogenetic tree based on 16S sequences it was 
determined that S. "purple" is a Streptomyces strain belonging to the S. violaceoruber 
clade. Interestingly the namesake and other members of the clade that S. "purple" 
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was placed into have the Latin prefix for violet, viola-, in their species names 
(Duangmal et al 2005) which is reminiscent of the purple pigment produced by 
S. "purple" when grown on GA agar. These results confirmed that the biological 
material of this strain was of Streptomyces origin.  
The phylogenetic tree correctly grouped relationships within each of the 
S. violaceoruber (Duangmal et al 2005), S. albidoflavus (Rong et al 2009) and 
S. griseus clades (Rong & Huang 2010) with high bootstrap support values. 
Members of the Kitasatospora genus were nested within Streptomyces, which is 
consistent with a recent phylogenetic studies of Kitasatospora and Streptomyces 
species (Labeda et al 2012, Girard et al 2013, Girard et al 2014), indicating that 
Streptomyces is a paraphyletic genus.  
 
The phylogenetic tree could have been improved by removing sequences from the 
analysis and changing the outgroup from M. tuberculosis to an organism more 
closely related to Streptomyces, like Motilibacter peucedani. 
 
4.2 STEM imaging of vesicles in droplets produced by S. "purple" 
To support work with EVs produced by S. nodosus, methods of imaging 
Streptomyces vesicles with STEM were first developed using droplets produced by 
S. "purple" as a model. EVs of sizes ~60 - 120 nm were observed in the S. "purple" 
droplet samples. These spherical structures shared the same morphology as 
Streptomyces EVs imaged with TEM, although they were somewhat smaller than 
S. coelicolor EVs that were 80 - 400 nm (Schrempf et al  2011) and S. lividans EVs 
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that were 20 - 230 nm (Schrempf & Merling 2015).  After S. coelicolor and 
S. lividans, S. "purple" is the third Streptomyces species to have EV content in 
droplet exudates observed by electron microscopy, which supports the idea that 
delivery of biomolecules via this process is widespread amongst the genus. In 
addition, this is the first time STEM has been used to image Streptomyces EVs, 
although STEM has been used previously to image EVs of virus particles (Burlaud-
Gailard et al 2014). Having a developed method for imaging Streptomyces EVs with 
STEM facilitated the imaging of EVs isolated from the culture broth of S. nodosus 
strains. 
 
4.3 Imaging EVs isolated from culture broth extracts of S. nodosus strains  
The existence of EVs in the culture broths of S. nodosus strains was confirmed using 
STEM. This is the first time EVs have been detected in S. nodosus culture broth. EVs 
were detected in the culture broth extracts of the knockout mutant S. nodosus 
MAΩhyg that had the same morphology and size (84 ± 33 nm) as EVs of the 
wildtype. Production of vesicles by the mutant strain was expected as EVs are 
utilised by organisms in the three domains of life for a diverse range of processes 
beyond the delivery of polyketide drugs (Deatherage & Cookson 2012, Brown et al 
2015, Schwechheimer & Kuehn 2015). This means that EVs are used by S. nodosus 
to deliver or protect important molecules other than amphotericin B. 
 
EVs were not observed in a <100 kDa fraction of S. nodosus culture broth using 
STEM, showing that size fractionation is an effective technique to extract EVs from 
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culture fluid. This result supported the co-localisation experiments by confirming the 
<100 kDa size fractionated sample of S. nodosus culture broth was free of EVs. 
 
To verify that the STEM images were of high quality, vesicles produced by wildtype  
S. nodosus were also imaged using TEM. The images of S. nodosus vesicles obtained 
in this study using STEM had better resolution than the images taken with TEM 
using identical sample preparation. Some of this may be attributed to having less 
operational experience using a TEM rather than TEM being an inferior technique to 
STEM. The TEM images did show a greater contrast of EVs with background 
material compared to EVs in the STEM images which is likely due to the TEM 
operating at 100 kV compared to 30 kV for STEM. These results show that for the 
imaging of Streptomyces EVs, STEM is an effective alternative to TEM.  
 
Our sample preparation for STEM imaging of EVs could have been improved by 
gathering enough volume of droplet or vesicle samples so that TEM grids could be 
fully immersed inside drops (~100 µL) of the samples prior to fixation and staining.  
 
4.4 Co-localisation of S. nodosus EVs with amphotericin B 
The co-localisation of amphotericin B with EVs during size fractionation is the first 
evidence indicating that S. nodosus may use EVs to improve the solubility of 
amphotericin B in culture fluid. If this is correct then further characterisation may 
lead to improved therapeutic delivery systems of amphotericin B based on S. nodosus 
EVs, however more evidence is needed to conclude this definitively. 
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4.5 Future work 
There are has several additional areas for further investigation as a result of this 
project, some of which could not be attempted due to time constraints. Further 
phylogenetic work could be undertaken to determine classification of Kitasatospora 
species and closely related Streptomyces species. The analysis could include the 
recently identified taxonomic marker SsgB. The amino acid sequences of SsgB 
proteins showed distinct differences between Kitasatospora and Streptomyces 
(Girard et al 2013, Girard et al 2014) and should be included in future phylogenetic 
reconstruction with a broader range of species. 
 
Our UV-Vis analysis showed a qualitative relationship between S. nodosus EVs and 
amphotericin B concentration, however, quantifying this relationship with HPLC was 
the ultimate goal. To ascertain this relationship, vesicle isolation procedures need to 
be improved. Isolating EVs by size fractionation was sufficient for image analysis 
and preliminary co-localisation experiments, however, future studies need to be sure 
EVs are responsible for the effects we have seen. Purification of EVs using sucrose 
gradients (Klimentová & Stulík 2014) would allow further confidence that any 
amphotericin B detected via HPLC is associated with EVs and not other >100 kDa 
content. Once this is confirmed, chemical characterisation of the EVs could be 
undertaken. 
 
One promising direction for this research is the loading of amphotericin B into EVs. 
Projects in our lab have shown that amphotericin B had improved solubility in the 
conditioned culture media of S. nodosus MAΩhyg compared with YMG media 
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(Pereira 2007). In these experiments the media would have contained EVs from the 
amphotericin B deficient mutant which may have been responsible for the increased 
amphotericin B concentration. To investigate if these EVs package amphotericin B, 
they should first be isolated and purified through a sucrose gradient. Amphotericin B 
could be added to dilutions of purified EVs in DMSO until saturation and analysed 
with HPLC. Additional HPLC analysis could be performed on EVs loaded with 
amphotericin B using sonication, which can be used to package molecules into 
liposomes (Akbarzadeh et al 2013).  
  
The association of amphotericin B with S. nodosus EVs and loaded S. nodosus 
MAΩhyg EVs can be further demonstrated by confocal fluorescence microscopy. 
This technique has been used to show amphotericin B is associated with the 
membrane of giant unilamellar vesicles, liposomes that are ~10 µm in diameter 
(Grudzinkski et al 2016). Using this technique it should also be possible to show a 
similar phenomenon occurring within natural EVs, although the comparatively small 
size of S. nodosus EVs (~100 nm) may bring challenges. 
 
4.6 Conclusion 
There is a current need for improved treatments for systemic fungal mycoses. To 
solve this problem, EVs are being explored to improve antifungal drug delivery. 
Further characterisation of the mechanisms used by S. nodosus for hydrophobic drug 
delivery in nature may lead to insights important for the drug delivery of 
amphotericin B and treatment of serious fungal infections. Any knowledge gained 
could potentially be expanded to other hydrophobic drugs.  
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APPENDIX 1  
 
Forward 16S rDNA sequence of S. "purple" sample 1 
  1        10        20        30        40        50 
  |        |         |         |         |         | 
  AAAAGCGTTACGACTTCGCTAAGCTCGCCGCTTGCATAACATTGCACGTC 
  GAACGATGAATTTTTCGGTGGTGATTACTGGCCAACGTGTGATTAACACA 
  TTACCCAATCTGCCCTTCACTCTGGGACAAGCCTTGAAAACAGGGTCTAA 
  TACCGGATACTGACCCCCGCAAGCATCTGCGAGGTTCGAAAGCTCCGGCG 
  GCGTTTGATGACTTCGCGGCCTATCCCCTTGTTGGTGAGGTAACGGCTCA 
  CCCCTGCGACAAAAGTTACCCTGCCTGCCAGGGCGACCGGCCACTATGTG 
  ACTGAGACCCGCCCCCGACTCCTAATTTAGGCAGCATTGATAACCCCCCC 
  CTTGGGGCCAAATCCTGATGCCCCCACGCCGCGAGAAGGACGACCGCTTT 
  TGGGTTGTATACCTCTTGCGGCAGGGCGAATTTTTTCCGGTTTTTCCCTG 
  ATGAATGCCCGCTGCTATCTCTGTGGCCGCCTCAACGAAGATTCTTATGT 
  TGCACTTTTTGCACGGAAACCACCCCCACCAAAAACACTTTTGTTTCCCT 
  CGTCCT 
 
 
 
 
Reverse 16S rDNA sequence of S. "purple" sample 1 
  1        10        20        30        40        50 
  |        |         |         |         |         | 
  GGCGAAAATACTCTCTTGGCAGCAGCTTCTCTTCCGTCATGGGACCGTGC 
  GACATGCCTATTCATACGAAACTCGGCCCATGGAACATGCTATGCTCGGT 
  TTTGCCCTGGGTATTCTCAAAAAGAAGTTCTCCTAAAAAAAACCGCCGCC 
  CAGGTTTAGACGCCAATCTAGTGCACCCTACCAAAACACGCCGATTCGGT 
  TATGTATGTTTAGGATCGTACGTCGTAGTGAGCAGTACCCTCCACCGCCT 
  TGAATATAAGTAACACTGCCATCTATGCAAAGTCCTAAATAATATTCCAC 
  ACTGCTCATTCGTAATTGTACGAGGAATGAATTATGACTCCGGCCTCTAA 
  CCCGAAGAACCCACCGGATGAACGGACCTGAAGACGACGAACAAGAAATT 
  CATCCCTCTAGTGGAGACTCGGGGTATTGATAGGGTTACTAAATTGAACG 
  CGAAATCGCTATCTCTGTTATCGCCGGAATAACGTTTCTTTTGTTACAAA 
  TAGGCTTTGGTATCCGCCTCCACGACAAACCCCATTTCTTTGCCGGTGAA 
  CGCCAAGTAGACGAAGGAATGACCCGTATCCACGCCAAGCCGGTACATGT 
  AGATACAAAGAAAACTGTGAATTTGATTCGCTGAAGGTCCACCTTTTCAC 
  GCTATTAGTGGAGGCATCCGTG 
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Forward 16S rDNA sequence of S. "purple" sample 2 
  1        10        20        30        40        50 
  |        |         |         |         |         | 
  TCGAACGATGAACCACTTCGGTGGGGATTAGTGGCGAACGGGTGAGTAAC 
  ACGTGGGCAATCTGCCCTTCACTCTGGGACAAGCCCTGGAAACGGGGTCT 
  AATACCGGATACTGACCCTCGCAGGCATCTGCGAGTTTCGAAAGCTCCGG 
  CGGTGAAGGATGAGCCCGCGGCCTATCATCTTGTTGGTGAGGTAATGGCT 
  CACCAAGGCGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTG 
  GGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATT 
  GCACAATGGGCGAAAGCCTGATGCAGCGACGCCGCGTGAGGGATGACGGC 
  CTTCGGGTTGTAAACCTCTTTCAGCATGGAAGAATCGAAAGTGACCTGTA 
  CCTGCCGAACAAGCGCCGGCTAACTACGTG 
  
 
 
Reverse 16S rDNA sequence of S. "purple" sample 2 
  1        10        20        30        40        50 
  |        |         |         |         |         | 
  TTCGTCCCAATCGCCAGTCCCACCTTCGACAGCTCCCTCCCACAAGGGGT 
  TGGGCCACCGGCTTCGGGTGTTACCGACTTTCGTGACGTGACGGGCGGTG 
  TGTACAAGGCCCGGGAACGTATTCACCGCAGCAATGCTGATCTGCGATTA 
  CTAGCGACTCCGACTTCATGGGGTCGAGTTGCATACCCCAATCCGAACTG 
  AGACCGGCTTTTTGAGATTCGCTCCACCTTGCGGTATCGCAGCTCATTGT 
  ACCGGCCATTGTACCACGTGTGCATCCCAAGACATAAGGGGCATGATGAC 
  TTGACGTCCTCCCCACCTTCCTCCGAGTTGACCCCGGCGGTCTCCCGTGA 
  GTCCCCAACACCCCGAAGGGCTTGCTGGCAACACGGGACAAGGGTTGCGC 
  TCGTTGCGGGACTTAACCCAACATCTCACGACACGAGCTGACGACAGCCA 
  TGCACCACCTGTACACCGACCACAAGGGGGGCACCATCTCTGATGCTTTC 
  CGGTGTATGTCAAGCCTTGGTAAGGTTCTTCGCGTTGCGTCGAATTAACC 
  CACATGCTCCGCCGCTTGTGCGGGCCCCCGTCAATTCCTTTGAGTTTTAG 
  CCTTGCGGCCGTACTCCCCAGGCGGGGCACTTAATGCGTTAGCTGCGGCA 
  CGGACAACGTGGAAATGTTGCCCCACACCTAGTGCCCACCGTTTAGGCGT 
  GCACTACCAGGGTATCTAATCCTGTTCGCTCCCCACGCTTTCTCTCCTCA 
  GCGTCAGTATCGGCCCCAGAGATCCGTCTTCGCCACCGGTAGTCCCTCCT 
  GATATCTGCGCATTTCACCGCTACACCAGGAAATTCAGATCTCC 
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APPENDIX 2 
 
 1454 bp 16S rDNA sequence of S. "purple" 
  1        10        20        30        40        50 
  |        |         |         |         |         | 
  NNNNTCGAACGATGAACCACTTCGGTGGGGATTAGTGGCGAACGGGTGAG 
  TAACACGTGGGCAATCTGCCCTTCACTCTGGGACAAGCCCTGGAAACGGG 
  GTCTAATACCGGATACTGACCCTCGCANGCATCTGCGAGNNNNGAAAGCT 
  CCNGCGGTGAAGGATGAGCCCGCGGCCTATCNNCTTGTTGGTGAGGTAAT 
  GGCTCACCNNGGCGACNACGGGTAGCCGGCCNGANAGGGCGACCGGCCNC 
  ANTGGNACTGANACACGGCCCAGACTCCTANGGGAGGNAGCNNTGGGGAA 
  TATTGNNCAATGGGCGAAAGCCNGATGCAGCGACGCCGCGTGAGGGATGA 
  CGGCCTTCNGGTTGTAAACCTCTTTCNNCANGNAANNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
  NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNTTAATTCGACGCAANGC 
  GAAGAACCTTACCAAGGCTTGACATACNCNNGAAAGCATCAGAGATGGTG 
  CCCCCNTNGTGGNNGGNGTACAGGTGGNGCANGGCTGTCGTCAGNTCGTG 
  TCGTGAGATGTTGGGTTAAGTCCNGCAACGAGCGNAACCCTTGTNNNNTG 
  TTGNCAGCAAGCCNTTNGGGGTGTTGGGGACTCACGGGAGACCGCCGGGG 
  TCAANTCGGAGGAAGGTGGGGANGANGTCAAGTCATCANGCCCNTTATGT 
  NTTGGGNTGCACACGTGNTNCAATGGCCGGTACAATGAGNTGNGATACCG 
  CAAGGTGGAGNGAATCTCAAAAAGCNGGTCTCAGTTNGGATNGGGGTNTG 
  CAACTCGACCCCATGAAGTCGGAGTCGNTAGTNNNNGCAGATCAGCATTG 
  NTGCGGNGAATACGTTCCCGGGCCTTGTACACACNGCCNGTCACGTCNNG 
  AAAGTNGGTAACACCNGAAGCCGGTGGCCCAACCCCNNGTGGGAGGGAGC 
  TGTT 
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APPENDIX 3 
Table: A3.1 Sequence accession table for 16S rDNA sequences used for 
phylogenetic analysis 
Organism Accession number 
Kitasatospora atroaurantiaca DQ026645.1 
Kitasatospora mediocidica U93324.1 
Mycobacterium tuberculosis AM283534 
Streptomyces acrimycini AY999889.1 
Streptomyces albidochromogenes AB249953.1 
Streptomyces albidoflavus AB184255.1 
Streptomyces albofaciens AB045880.1 
Streptomyces alboflavus EF178699.1 
Streptomyces alboniger AY845349.1 
Streptomyces alboviridis AB184256.1 
Streptomyces ambofaciens AB184182.1 
Streptomyces anthocyanicus AB184631.1 
Streptomyces antibioticus AY999776.1 
Streptomyces anulatus DQ026637.1 
Streptomyces ardus AB184864.1 
Streptomyces avicenniae EU399234.1 
Streptomyces bohaiensis KF682221.2 
Streptomyces cacaoi AB184183.1 
Streptomyces caeruleus EF178675.1 
Streptomyces canarius AB184396.1 
Streptomyces candidus DQ026663.1 
Streptomyces carpaticus DQ442494.1 
Streptomyces celluloflavus AB184476.2 
Streptomyces champavatii DQ026642.1 
Streptomyces chattanoogensis AY295791.1 
Streptomyces cheonanensis AY822606.1 
Streptomyces chromofuscus AB184194.1 
Streptomyces chryseus AY999787.1 
Streptomyces coelescens AF503496.1 
Streptomyces coelicoflavus AB184650.1 
Streptomyces coelicolor AB184196.1 
Streptomyces decoyicus EU170127.1 
Streptomyces demainii DQ334782.1 
Streptomyces deserti HE577172.1 
Streptomyces erringtonii HE573871.1 
Streptomyces exfoliatus AB184324.1 
Streptomyces ferralitis AY262826.1 
Streptomyces filamentosus AB184130.1 
Streptomyces fradiae DQ026630.1 
Streptomyces fragilis AY999917.1 
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Organism Accession number 
Streptomyces galbus X79852.1 
Streptomyces galilaeus AB045878.1 
Streptomyces ghanaensis AY999851.1 
Streptomyces gibsonii AB184663.1 
Streptomyces glaucinger AB249964.1 
Streptomyces globosus AJ781330.1 
Streptomyces gobitricini AB184666.1 
Streptomyces griseoflavus AJ781322.1 
Streptomyces griseofuscus AB184206.1 
Streptomyces griseoluteus AY999751.1 
Streptomyces griseoruber AB184209.1 
Streptomyces griseus AY207604.1 
Streptomyces hawaiiensis AB184143.1 
Streptomyces heliomycini AB184712.1 
Streptomyces hiroshimensis AB249922.1 
Streptomyces humidus DQ442508.1 
Streptomyces humiferus AF503491.1 
Streptomyces labedae AB184704.1 
Streptomyces lanatus AB184845.1 
Streptomyces laurentii AJ781342.1 
Streptomyces lavendofoliae AJ781336.1 
Streptomyces lavendulocolor DQ442516.1 
Streptomyces leeuwenhoekii EU551711.2 
Streptomyces lienomycini AJ781353.1 
Streptomyces lilanicus AB184819.1 
Streptomyces longwoodensis AB184580.1 
Streptomyces lydicus Y15507.1 
Streptomyces macrosporus Z68099.1 
Streptomyces marinus AB473554.1 
Streptomyces mauvecolor AB184532.1 
Streptomyces megasporus AB184617.1 
Streptomyces melanogenes AB184222.1 
Streptomyces microflavus AY999869.1 
Streptomyces monomycini DQ445790.1 
Streptomyces mutabilis EF178679.1 
Streptomyces niger AJ621607.2 
Streptomyces nodosus AF114033.1:1001-2528 
Streptomyces olivochromogenes AY094370.1 
Streptomyces pactum AB184398.1 
Streptomyces panacagri AB245388.1 
Streptomyces pilosus AB184161.1 
Streptomyces polymachus KM229363.1 
Streptomyces prunicolor DQ026659.1 
Streptomyces rameus AY999821.1 
Streptomyces ramulosus DQ026662.1 
Streptomyces rangooensis AB184295.1 
Streptomyces rapamycinicus EF408733.1 
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Organism Accession number 
Streptomyces rosealbus AY222322.1 
Streptomyces ruber AB184604.1 
Streptomyces rubidus AY876941.1 
Streptomyces rubrisoli KC137299.1 
Streptomyces rubrogriseus AB184681.1 
Streptomyces sampsonii D63871.1 
Streptomyces sannanensis AB184579.1 
Streptomyces scabiei D63862.1 
Streptomyces scabrisporus AB030585.1 
Streptomyces septatus AY999925.1 
Streptomyces showdoensis AB184389.1 
Streptomyces subrutilis X80825.1 
Streptomyces tacrolimicus FN429653.1 
Streptomyces tendae D63873.1 
Streptomyces tricolor AB184687.1 
Streptomyces tritolerans DQ345779.2 
Streptomyces tsukubensis AB217600.1 
Streptomyces venezuelae AB045890.1 
Streptomyces violaceolatus AF503497.1 
Streptomyces violaceorectus AB184314.1 
Streptomyces violaceoruber AF503492.1 
Streptomyces violaceorubidis AJ781374.1 
Streptomyces violaceus AB184315.1 
Streptomyces violaceusniger AB184420.1 
Streptomyces violascens AY999737.1 
Streptomyces violatus AJ399480.1 
Streptomyces virens DQ442554.1 
Streptomyces virginiae AB184175.1 
Streptomyces xantholiticus AB184349.1 
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APPENDIX 4 
 Mean size of EVs produced by wildtype S. nodosus and S. nodosus MAΩhyg 
 
Figure A4.1: Extracellular vesicles isolated from S. nodosus culture broth. 
Images taken at the AMCF WSU using a JEOL 7001F SEM equipped with a TED 
detector in STEM mode at magnifications from 50,000 x - 350,000 x . 
59 
 
Table A4.1: Diameters of randomly selected S. nodosus vesicles 
Photo Vesicle Vesicle diameter 
(nm) 
p77 A 137 
p77 B 104 
p77 C 83 
p77 D 80 
p77 E 70 
p77 F 70 
p77 G 96 
p72 A 113 
p72 B 119 
p72 C 84 
p72 D 74 
p103 A 151 
p103 B 66 
p103 C 128 
p103 D 27 
p38 A 50 
p108 A 34 
p108 B 62 
p108 C 98 
p93 A 111 
p93 B 46 
p93 C 52 
n=22 average vesicle diameter = 84.31 ± 33.42 
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Figure A4.2: Extracellular vesicles isolated from S. nodosus MAΩhyg culture 
broth. Images taken at the AMCF WSU using a JEOL 7001F SEM equipped with a 
TED detector in STEM mode at magnifications from 50,000 x - 200,000 x .  
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Table A4.2: Diameters of randomly selected S. nodosus MAΩhyg vesicles 
Photo Vesicle Vesicle diameter 
(nm) 
p146 A 54 
p146 B 43 
p146 C 91 
p146 D 67 
p146 E 94 
p146 F 74 
p146 G 70 
p146 H 100 
p157 A 157 
p157 B 122 
p157 C 83 
p157 D 104 
p157 E 113 
p165 A 127 
p165 B 59 
p165 C 43 
p165 D 90 
p180 A 163 
p180 B 35 
p180 C 79 
p161 A 50 
p161 B 60 
p184 A 64 
p184 B 100 
p184 C 93 
p184 D 53 
n=26 average vesicle diameter = 84.15 ± 33.39 
 
 
